Evidence that the etiology of the syndrome containing type 2 diabetes mellitus results from abnormal magnesium metabolism

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 1-2, 2008, Pages 16-24

  Wells, Ibert C ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Etiology type 2 diabetes mellitus; Magnesium binding defect; Magnesium binding promoters

Indexed keywords

ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATE; INSULIN; MAGNESIUM ION; SATURATED FATTY ACID; SODIUM;

CALORIC RESTRICTION; CELL MEMBRANE; DIET SUPPLEMENTATION; ESSENTIAL HYPERTENSION; EXERCISE; GENETIC PREDISPOSITION; HUMAN; INSULIN RESISTANCE; LOW FAT DIET; MAGNESIUM METABOLISM; METAL BINDING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY;

ADENOSINE TRIPHOSPHATE; ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; LIPIDS; MAGNESIUM; MAGNESIUM DEFICIENCY;

EID: 39549112745     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y07-122     Document Type: Review

References (41)

1. Allen, B.D., and Greer, F.R. 1995. Calcium and magnesium metabolism beyond infancy. In Calcium and magnesium metabolism in early life. Edited by R.C. Tsang. CRC Press, Boca Raton, Fla. pp. 136-138.
2. Balon, T.W., Jasman, A., Scott, S., Meehan, W.F., Rude, R.K., and Nadler, J.L. 1994. Dietary magnesium prevents fructose-induced insulin insensitivity in rats. Hypertension, 23: 1036-1039.
3. Balon, T.W., Gu, J.L., Tokuyama, Y., Jasman, A.P., and Nadler, H. 1995. Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am. J. Physiol. 269: E745-E752.
4. Boden, G., Chen, X., Rosner, J., and Barton, M. 1995. Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes, 44: 1239-1242. doi:10.2337/diabetes.44.10.1239.
5. Bogardus, C., Lillioja, S., Howard, B.V., Reaven, G., and Mott, D. 1984. Relationship between insulin secretion, insulin action, and fasting glucose concentration in non-diabetic and non-insulin dependent subjects. J. Clin. Invest. 74: 1238-1246.
6. Bonadonna, R.C., Del Prato, S., Bonora, E., Saccomani, M.P., Gilli, G., Natali, A., et al. 1996. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes, 45: 915-925. doi:10.2337/diabetes.45.7.915.
7. De Fronzo, R.A. 1997. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev. 5: 177-269.
8. Efendic, S., Kindmark, H., and Berggren, P.O. 1991. Mechanisms involved in the regulation of the insulin secretory process. J. Intern. Med. Suppl. 735: 9-22.
9. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. 1997. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20: 1187-1197.
10. Falholt, K., Jensen, I., Lindkaer-Jensen, S., Mortensen, H.B., Volund, A., Heding, L.G., et al. 1998. Carbohydrate and lipid metabolism in skeletal muscle in type 2 diabetes patients. Diabet. Med. 5: 27-31.
11. Hall, J.E., Brands, M.W., Dixon, W.N., and Smith, M.J., Jr. 1993. Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension, 22: 292-299.
12. Hoppener, J.W.M., Ahren, B., and Lips, C.J.M. 2000. Islet amyloid and type 2 diabetes mellitus. N. Engl. J. Med. 343: 411-419. doi:10.1056/NEJM200008103430607.
13. Hua, H., Gonzales, J., and Rude, R.K. 1995. Magnesium transport induced ex-vivo by a pharmalogical dose of insulin is impaired in non-insulin dependent diabetes mellitus. Magnes. Res. 8: 359-366.
14. Hwang, I.-S., Ho, H., Hoffman, B.B., and Reaven, G.M. 1987. Fructose induced insulin resistance and hypertension in rats. Hypertension, 10: 512-516.
15. Kelley, D.E., Mintun, M.A., Watkins, S.C., Simoneau, J.-A., Jadali, F., Fredrickson, A., et al. 1996. The effect of non-insulin dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J. Clin. Invest. 97: 2705-2713.
16. Krotkiewski, M., Mandioukas, K., Sjostrom, L., Sullivan, L., Wetterqvist, H., and Bjomtrop, P. 1979. Effects of long-term physical training on body fat, metabolism and blood pressure in obesity. Metabolism, 28: 650-658. doi:10.1016/0026-0495(79)90018-0.
17. Leghninger, A.L. 1975. Biochemistry. 2nd ed. Worth Publishers, New York. p. 390.
18. Leslie, R.D.F., and Pyke, D.A. 1987. Genetics of diabetes. In Diabetes Annual/3. Edited by K.G.M.M. Alberti and L.P. Krall. Elsevier, Amsterdam. pp. 39-5.
19. Man, Z.-W., Hirashima, T., Mori, S., and Kawano, K. 2000. Decrease in triglyceride accumulation in tissues by restricted diet and improvement of diabetes in Otuska Long-Evans Tokushima fatty rats, a non-insulin dependent model. Metabolism, 49: 108-114. doi:10.1016/S0026-0495(00)90913-2.
20. Matsas, R., Rattray, M., Kenny, J., and Turner, A.J. 1985. The metabolism of neuropeptides. Endopeptidase 24.11 in human synaptic preparations hydrolyzes substance P. Biochem. J. 228: 487-492.
21. Mattingly, M.T., Brzezinski, W.A., and Wells, I.C. 1991. Decreased cell membrane magnesium in some essential hypertension patients. Clin. Exp. Hypertens. A, 13: 65-82.
22. Matuura, T., Kohno, M., Kanyama, Y., Yasunari, K., Murakawa, K., Takeda, T., et al. 1987. Decreased intracellular free magnesium in erythrocytes of spontaneous hypertensive rats. Biochem. Biophys. Res. Commun. 143: 1012-1017. doi:10.1016/0006-291X(87)90352-4.
23. Montgomery, R., Dryer, R.L., Conway, T.W., and Spector, A.A. 1977. Aminoacyl-transfer RNA syntheses. Biochemistry, a case-oriented approach. 2nd ed. The C.V. Mosby Co., St. Louis.
24. Mori, Y., Murakawa, Y., Katoh, S., Yokoyama, J., Tajima, N., Ikeday, Y., et al. 1997. Influence of highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin dependent diabetes mellitus. Metabolism, 46: 1458-1464. doi:10.1016/S0026-0495(97)90148-7.
25. Ohneda, M., Inman, L.R., and Unger, R.H. 1995. Caloric restriction in obese pre-diabetic rats prevents β-cell depletion, loss of β-GLUT 2 and glucose incompetence. Diabetologia, 38: 173-179. doi:10.1007/ BF00400091.
26. Phillips, D.I.W., Caddy, S., Illic, V., Fielding, B.A., Frayn, K.N., Bortwick, A.C., et al. 1996. Intramuscular triglyceride and muscle sensitivity: evidence for a relationship in non-diabetic subjects. Metabolism, 45: 947-950. doi:10.1016/S0026-0495(96)90260-7.
27. +-ATPase regulation in Dahl salt-sensitive and salt-resistant rats. J. Biol. Chem. 263: 11056-11058.
28. Reaven, G.M., and Chang, H. 1991. Relationship between blood pressure, plasma insulin, and triglyceride concentration, and insulin action in SHR and WKY rats. Am. J. Hypertens. 4: 34-38.
29. Reaven, G.M., Twersky, J., and Chang, H. 1991. Abnormalities of carbohydrate and lipid metabolism in Dahl rats. Hypertension, 18: 630-635.
30. Resnick, L.M., Gupta, R.K., and Laragh, J.H. 1984. Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. Proc. Natl. Acad. Sci. U.S.A. 81: 6511-6515. doi:10.1073/pnas.81.20.6511.
31. Rissler, K. 1995. Sample preparation, high-performance liquid chromatographic separation and determination of substance P-related peptides. J. Chromatogr. B Biomed. Appl. 665: 233-270. doi:10.1016/0378-4347(94) 00533-B.
32. Rochini, A.P., Moorehead, C.P., Wentz, E., and DeRemer, S. 1987. Obesity-induced hypertension in dogs. Hypertension, 9(Suppl III): 64-68.
33. Rochini, A.P., Moorehead, C.P., DeRemer, S., and Bondie, D. 1989. Pathogenesis of weight related changes in blood pressure in dog. Hypertension, 13: 922-928.
34. Roden, M., Price, T.B., Perseghin, G., Petersen, K.F., Rothman, D.L., Cline, G.W., et al. 1996. Mechanism of free-fatty acid induced insulin resistance in humans. J. Clin. Invest. 97: 2859-2865.
35. Speich, M., Bousquet, B., and Nicolas, G. 1981. Reference values for ionized, complexed and protein-bound magnesium in men and women. Clin. Chem. 27: 246-248.
36. Stamler, R., Stamlar, J., Grimm, R., Gosch, F.C., Elmer, R., Dyer, A., et al. 1987. Nutritional therapy for high blood pressure, Final report of a four-year randomized controlled trial- the hypertension control program. JAMA, 257: 1484-1491. doi:10.1001/jama.257.11.1484.
37. Steen, E., Terry, B.M., Rivera, E.J., Cannon, J.L., Neely, T.R., Tavares, R., et al. 2005. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes. J. Alzheimers Dis. 7: 63-80.
38. Wells, I.C., and Agrawal, D.K. 1992. Abnormal magnesium metabolism in two rat models of genetic hypertension. Can. J. Physiol. Pharmacol. 70: 1225-1229.
39. Wells, I.C., and Blotcky, A.J. 2001. Coexisting independent sodium-sensitive and sodium-insensitive mechanisms of genetic hypertension in spontaneously hypertensive rats (SHR). Can. J. Physiol. Pharmacol. 79: 779-784. doi:10.1139/cjpp-79-9-779.
40. Wells, I.C., Agrawal, D.K., and Anderson, R.J. 2004. Abnormal magnesium metabolism in etiology of salt-sensitive hypertension and type 2 diabetes mellitus. Biol. Trace Elem. Res. 98: 97-108. doi:10.1385/BTER:98:2:097.
41. Zavaroni, I., Sander, S., Scott, S., and Reaven, G.M. 1980. Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism, 29: 970-973. doi:10.1016/0026-0495(80)90041-4.